Skip to main content
Top
Published in: Strahlentherapie und Onkologie 8/2015

01-08-2015 | Original Article

Wnt/β-catenin pathway involvement in ionizing radiation-induced invasion of U87 glioblastoma cells

Authors: Zhen Dong, MD, Lin Zhou, PhD, Na Han, MD, Mengxian Zhang, MD, Xiaojuan Lyu, MD

Published in: Strahlentherapie und Onkologie | Issue 8/2015

Login to get access

Abstract

Background

Radiotherapy has been reported to promote the invasion of glioblastoma cells; however, the underlying mechanisms remain unclear. Here, we investigated the role of the Wnt/β-catenin pathway in radiation-induced invasion of glioblastoma cells.

Methods

U87 cells were irradiated with 3 Gy or sham irradiated in the presence or absence of the Wnt/β-catenin pathway inhibitor XAV 939. Cell invasion was determined by an xCELLigence real-time cell analyser and matrigel invasion assays. The intracellular distribution of β-catenin in U87 cells with or without irradiation was examined by immunofluorescence and Western blotting of nuclear fractions. We next investigated the effect of irradiation on Wnt/β-catenin pathway activity using TOP/FOP flash luciferase assays and quantitative polymerase chain reaction analysis of β-catenin target genes. The expression levels and activities of two target genes, matrix metalloproteinase (MMP)-2 and MMP-9, were examined further by Western blotting and zymography.

Results

U87 cell invasiveness was increased significantly by ionizing radiation. Interestingly, ionizing radiation induced nuclear translocation and accumulation of β-catenin. Moreover, we found increased β-catenin/TCF transcriptional activities, followed by up-regulation of downstream genes in the Wnt/β-catenin pathway in irradiated U87 cells. Importantly, inhibition of the Wnt/β-catenin pathway by XAV 939, which promotes degradation of β-catenin, significantly abrogated the pro-invasion effects of irradiation. Mechanistically, XAV 939 suppressed ionizing radiation-triggered up-regulation of MMP-2 and MMP-9, and inhibited the activities of these gelatinases.

Conclusion

Our data demonstrate a pivotal role of the Wnt/β-catenin pathway in ionizing radiation-induced invasion of glioblastoma cells, and suggest that targeting β-catenin is a promising therapeutic approach to overcoming glioma radioresistance.
Literature
1.
go back to reference Gralow J, Ozols RF, Bajorin DF et al (2008) Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening–a report from the American society of clinical oncology. J Clin Oncol 26:313–325PubMedCrossRef Gralow J, Ozols RF, Bajorin DF et al (2008) Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening–a report from the American society of clinical oncology. J Clin Oncol 26:313–325PubMedCrossRef
2.
go back to reference Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef
3.
go back to reference Gerstein J, Franz K, Steinbach JP et al (2010) Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. Radiother Oncol 97:382–386PubMedCrossRef Gerstein J, Franz K, Steinbach JP et al (2010) Postoperative radiotherapy and concomitant temozolomide for elderly patients with glioblastoma. Radiother Oncol 97:382–386PubMedCrossRef
4.
5.
go back to reference Cheng JC, Chou CH, Kuo ML et al (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25:7009–7018PubMedCrossRef Cheng JC, Chou CH, Kuo ML et al (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25:7009–7018PubMedCrossRef
6.
go back to reference De Bacco F, Luraghi P, Medico E et al (2011) Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J Natl Cancer Inst 103:645–661PubMedCrossRef De Bacco F, Luraghi P, Medico E et al (2011) Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J Natl Cancer Inst 103:645–661PubMedCrossRef
7.
go back to reference Madani I, De Neve W, Mareel M (2008) Does ionizing radiation stimulate cancer invasion and metastasis? Bull Cancer 95:292–300PubMed Madani I, De Neve W, Mareel M (2008) Does ionizing radiation stimulate cancer invasion and metastasis? Bull Cancer 95:292–300PubMed
8.
go back to reference Fujita M, Otsuka Y, Yamada S et al (2011) X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, MIAPaCa-2, which exhibits mesenchymal and amoeboid motility. Cancer Sci 102:792–798PubMedCrossRef Fujita M, Otsuka Y, Yamada S et al (2011) X-ray irradiation and Rho-kinase inhibitor additively induce invasiveness of the cells of the pancreatic cancer line, MIAPaCa-2, which exhibits mesenchymal and amoeboid motility. Cancer Sci 102:792–798PubMedCrossRef
9.
go back to reference Wild-Bode C, Weller M, Rimner A et al (2001) Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61:2744–2750PubMed Wild-Bode C, Weller M, Rimner A et al (2001) Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61:2744–2750PubMed
10.
go back to reference Gliemroth J, Feyerabend T, Gerlach C et al (2003) Proliferation, migration, and invasion of human glioma cells exposed to fractionated radiotherapy in vitro. Neurosurg Rev 26:198–205PubMedCrossRef Gliemroth J, Feyerabend T, Gerlach C et al (2003) Proliferation, migration, and invasion of human glioma cells exposed to fractionated radiotherapy in vitro. Neurosurg Rev 26:198–205PubMedCrossRef
11.
go back to reference Zhai GG, Malhotra R, Delaney M et al (2006) Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway. J Neurooncol 76:227–237PubMedCrossRef Zhai GG, Malhotra R, Delaney M et al (2006) Radiation enhances the invasive potential of primary glioblastoma cells via activation of the Rho signaling pathway. J Neurooncol 76:227–237PubMedCrossRef
12.
go back to reference Moncharmont C, Levy A, Guy JB et al (2014) Radiation-enhanced cell migration/invasion process: a review. Crit Rev Oncol Hematol 92:133–142 Moncharmont C, Levy A, Guy JB et al (2014) Radiation-enhanced cell migration/invasion process: a review. Crit Rev Oncol Hematol 92:133–142
13.
go back to reference Scrace S, O’Neill E, Hammond EM et al (2013) Use of the xCELLigence system for real-time analysis of changes in cellular motility and adhesion in physiological conditions. Methods Mol Biol 1046:295–306PubMedCrossRef Scrace S, O’Neill E, Hammond EM et al (2013) Use of the xCELLigence system for real-time analysis of changes in cellular motility and adhesion in physiological conditions. Methods Mol Biol 1046:295–306PubMedCrossRef
14.
go back to reference Teng Y, Wang X, Wang Y et al (2010) Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun 392:373–379PubMedCrossRef Teng Y, Wang X, Wang Y et al (2010) Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells. Biochem Biophys Res Commun 392:373–379PubMedCrossRef
15.
go back to reference Vermeulen L, De Sousa EMF, van der Heijden M et al (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12:468–476PubMedCrossRef Vermeulen L, De Sousa EMF, van der Heijden M et al (2010) Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 12:468–476PubMedCrossRef
16.
go back to reference King TD, Suto MJ, Li Y (2012) The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. J Cell Biochem 113:13–18PubMedCrossRef King TD, Suto MJ, Li Y (2012) The Wnt/beta-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer. J Cell Biochem 113:13–18PubMedCrossRef
17.
go back to reference Yamashita T, Ji J, Budhu A et al (2009) EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136:1012–1024PubMedCentralPubMedCrossRef Yamashita T, Ji J, Budhu A et al (2009) EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136:1012–1024PubMedCentralPubMedCrossRef
18.
go back to reference Pala A, Karpel-Massler G, Kast RE et al (2012) Epidermal to mesenchymal transition and failure of EGFR-targeted therapy in glioblastoma. Cancers (Basel) 4:523–530CrossRef Pala A, Karpel-Massler G, Kast RE et al (2012) Epidermal to mesenchymal transition and failure of EGFR-targeted therapy in glioblastoma. Cancers (Basel) 4:523–530CrossRef
19.
go back to reference Kim Y, Kim KH, Lee J et al (2012) Wnt activation is implicated in glioblastoma radioresistance. Lab Invest 92:466–473PubMedCrossRef Kim Y, Kim KH, Lee J et al (2012) Wnt activation is implicated in glioblastoma radioresistance. Lab Invest 92:466–473PubMedCrossRef
20.
go back to reference Jin X, Jeon HY, Joo KM et al (2011) Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res 71:3066–3075PubMedCrossRef Jin X, Jeon HY, Joo KM et al (2011) Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation. Cancer Res 71:3066–3075PubMedCrossRef
21.
go back to reference Zheng H, Ying H, Wiedemeyer R et al (2010) PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell 17:497–509PubMedCentralPubMedCrossRef Zheng H, Ying H, Wiedemeyer R et al (2010) PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas. Cancer Cell 17:497–509PubMedCentralPubMedCrossRef
23.
go back to reference Timke C, Zieher H, Roth A et al (2008) Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res 14:2210–2219PubMedCrossRef Timke C, Zieher H, Roth A et al (2008) Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy. Clin Cancer Res 14:2210–2219PubMedCrossRef
24.
go back to reference Park CM, Park MJ, Kwak HJ et al (2006) Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res 66:8511–8519PubMedCrossRef Park CM, Park MJ, Kwak HJ et al (2006) Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res 66:8511–8519PubMedCrossRef
25.
go back to reference Ji H, Wang J, Nika H et al (2009) EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin. Mol Cell 36:547–559PubMedCentralPubMedCrossRef Ji H, Wang J, Nika H et al (2009) EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin. Mol Cell 36:547–559PubMedCentralPubMedCrossRef
26.
go back to reference Zhou BP, Deng J, Xia W et al (2004) Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6:931–940PubMedCrossRef Zhou BP, Deng J, Xia W et al (2004) Dual regulation of Snail by GSK-3beta-mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 6:931–940PubMedCrossRef
27.
go back to reference Luu H, Zhang R, Haydon R et al (2004) Wnt/β-catenin signaling pathway as novel cancer drug targets. Current Cancer Drug Targets 4:653–671PubMedCrossRef Luu H, Zhang R, Haydon R et al (2004) Wnt/β-catenin signaling pathway as novel cancer drug targets. Current Cancer Drug Targets 4:653–671PubMedCrossRef
28.
go back to reference Wu B, Crampton SP, Hughes CC (2007) Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26:227–239PubMedCentralPubMedCrossRef Wu B, Crampton SP, Hughes CC (2007) Wnt signaling induces matrix metalloproteinase expression and regulates T cell transmigration. Immunity 26:227–239PubMedCentralPubMedCrossRef
31.
go back to reference Wick W, Platten M, Weller M (2001) Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neurooncol 53:177–185PubMedCrossRef Wick W, Platten M, Weller M (2001) Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J Neurooncol 53:177–185PubMedCrossRef
32.
go back to reference Platten M, Wick W, Weller M (2001) Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech 52:401–410PubMedCrossRef Platten M, Wick W, Weller M (2001) Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape. Microsc Res Tech 52:401–410PubMedCrossRef
33.
go back to reference Huang SM, Mishina YM, Liu S, et al (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614–620PubMedCrossRef Huang SM, Mishina YM, Liu S, et al (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614–620PubMedCrossRef
34.
go back to reference Fancy SP, Harrington EP, Yuen TJ et al (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14:1009–1016PubMedCentralPubMedCrossRef Fancy SP, Harrington EP, Yuen TJ et al (2011) Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 14:1009–1016PubMedCentralPubMedCrossRef
35.
go back to reference Zhao JW, Dyson SC, Kriegel C, et al (2014) Modelling of a targeted nanotherapeutic ‘stromaʼ to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-beta-catenin signalling, for use in human fetal dopaminergic grafts in Parkinsonʼs disease. Dis Model Mech 7:1193–1203PubMedCentralPubMedCrossRef Zhao JW, Dyson SC, Kriegel C, et al (2014) Modelling of a targeted nanotherapeutic ‘stromaʼ to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-beta-catenin signalling, for use in human fetal dopaminergic grafts in Parkinsonʼs disease. Dis Model Mech 7:1193–1203PubMedCentralPubMedCrossRef
36.
go back to reference Barker N, Clevers H (2006) Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 5:997–1014PubMedCrossRef Barker N, Clevers H (2006) Mining the Wnt pathway for cancer therapeutics. Nat Rev Drug Discov 5:997–1014PubMedCrossRef
Metadata
Title
Wnt/β-catenin pathway involvement in ionizing radiation-induced invasion of U87 glioblastoma cells
Authors
Zhen Dong, MD
Lin Zhou, PhD
Na Han, MD
Mengxian Zhang, MD
Xiaojuan Lyu, MD
Publication date
01-08-2015
Publisher
Springer Berlin Heidelberg
Published in
Strahlentherapie und Onkologie / Issue 8/2015
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-015-0858-7

Other articles of this Issue 8/2015

Strahlentherapie und Onkologie 8/2015 Go to the issue